PYC Therapeutics (Australia) Probability of Future Stock Price Finishing Over 1.40
| PYC Stock | 1.40 0.05 3.45% |
PYC |
PYC Therapeutics Target Price Odds to finish over 1.40
The tendency of PYC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.40 | 90 days | 1.40 | about 98.0 |
Based on a normal probability distribution, the odds of PYC Therapeutics to move above the current price in 90 days from now is about 98.0 (This PYC Therapeutics probability density function shows the probability of PYC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon PYC Therapeutics has a beta of -0.18 indicating as returns on the benchmark increase, returns on holding PYC Therapeutics are expected to decrease at a much lower rate. During a bear market, however, PYC Therapeutics is likely to outperform the market. Additionally PYC Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. PYC Therapeutics Price Density |
| Price |
Predictive Modules for PYC Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as PYC Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.PYC Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. PYC Therapeutics is not an exception. The market had few large corrections towards the PYC Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold PYC Therapeutics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of PYC Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 0.18 | |
Ir | Information ratio | -0.01 |
PYC Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of PYC Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for PYC Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| PYC Therapeutics generated a negative expected return over the last 90 days | |
| PYC Therapeutics may become a speculative penny stock | |
| PYC Therapeutics has high historical volatility and very poor performance | |
| PYC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.06 M. Net Loss for the year was (37.73 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| PYC Therapeutics has accumulated about 15.57 M in cash with (38.59 M) of positive cash flow from operations. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders |
PYC Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of PYC Stock often depends not only on the future outlook of the current and potential PYC Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. PYC Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 3.9 B | |
| Cash And Short Term Investments | 66.9 M |
PYC Therapeutics Technical Analysis
PYC Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. PYC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of PYC Therapeutics. In general, you should focus on analyzing PYC Stock price patterns and their correlations with different microeconomic environments and drivers.
PYC Therapeutics Predictive Forecast Models
PYC Therapeutics' time-series forecasting models is one of many PYC Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary PYC Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about PYC Therapeutics
Checking the ongoing alerts about PYC Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for PYC Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| PYC Therapeutics generated a negative expected return over the last 90 days | |
| PYC Therapeutics may become a speculative penny stock | |
| PYC Therapeutics has high historical volatility and very poor performance | |
| PYC Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 22.06 M. Net Loss for the year was (37.73 M) with profit before overhead, payroll, taxes, and interest of 15.81 M. | |
| PYC Therapeutics has accumulated about 15.57 M in cash with (38.59 M) of positive cash flow from operations. | |
| Roughly 59.0% of the company outstanding shares are owned by corporate insiders |
Additional Tools for PYC Stock Analysis
When running PYC Therapeutics' price analysis, check to measure PYC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PYC Therapeutics is operating at the current time. Most of PYC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PYC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PYC Therapeutics' price. Additionally, you may evaluate how the addition of PYC Therapeutics to your portfolios can decrease your overall portfolio volatility.